The potential gaps in access come at a peak time in respiratory virus season, when breathing conditions like asthma, commonly treated with the inhalers, are more likely to be exacerbated.
Starting Jan. 1, a cap was lifted on how much manufacturers would have to rebate Medicaid if their prices rose faster than inflation.
[
Collection
]
[
|
...
]